bartfai造句

• Bartfai has made a large impact on studying fever and its neuroscientific origins.
• I am not Tamas Bartfai, but I am a writer and published author.
• Tamas Bartfai knows probably a hundred personally.
• Bartfai participated in developing the enzymatic, non-chlorine paper bleaching for BillerudKorsn鋝 and Tetra Pak.
• The Romanians finished at 34.349, while Hungarians Zsolt Gyulay and Krisztian Bartfai grabbed bronze at 34.423.
• For example, Bruno Conti and Bartfai used a grant from Larry Ellison of Oracle Corporation to create the  coolmouse.
• Scripps'Tamas Bartfai, writing in a recent issue of the Pharmacogenomics Journal published by Nature, said politicians must become involved.
• "This trend to broaden genotypic knowledge about individuals in populations has to be carefully monitored at the political levels of society, " Bartfai says.
• Norwegian kayakers Erik Larsen and Nils Fjeldheim won the K-2 1000 meters, beating Krisztian Bartfai and Krisztian Vereb of Hungary in second place by over two seconds.
• Bartfai showed with Tomas H鰇felt, Marianne Schultzberg, and Jan M . Lundberg firstly that ACh and vasoactive intestinal peptide ( VIP ) can coexist in nerve terminals and act synergistically when released.
• Research on the coexistence of classical transmitters and neuropeptides, and frequency-dependent chemical coding led to Bartfai receiving the 1992 Eriksson prize shared with H錵an Persson, who discovered brain derived neurotrophic factor ( BDNF ).
• With Per Askel鰂 and Stefan B . Svenson, Tamas Bartfai created the first "'acellular pertussis "'( whooping cough ) "'vaccine "'that is part of the present triple vaccine.
• Bartfai has published two books with Graham Lees, Ph . D ., on drug discovery and development :  "'Drug Discovery : from bedside to Wall Street "' and  "'The Future of Drug Discovery : who decides which diseases to treat ? "', which are both also published in Japanese and Mandarin.
• Bartfai has been involved as a consultant at almost all large pharmaceutical companies, including depression ( zimelidine, and later alaproclate ), the first proton-pump inhibitor ( omeprazol / Losec-Prilosec  the most successful drug of all time ) for  heartburn, as a consultant to Roche, the catechol-O-methyltransferase ( COMT ) inhibitor ( Tasmar-tolcapone ) used in Parkinson s Disease, the first benzodiazepine antagonist ( flunitrazepam ) for treatment of benzodiazepine overdoses, and as a consultant to Novartis the sphingosine 1-phosphate ( S1P ) agonist Gilenya-fingolimod as the first oral multiple sclerosis ( MS ) drug.